Congress Needs To Review “Authorized” Generics, Hatch And Waxman Agree

Congress will likely have to look at the issue of "authorized" generics, Sen. Orrin Hatch (R-Utah) and Rep. Henry Waxman (D-Calif.) said during an Oct. 6 Drug & Device Dialogue audio conference sponsored by FDC Reports and Polidais LLC